We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSNP.L Regulatory News (SNP)

  • There is currently no data for SNP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

29 Apr 2020 10:03

RNS Number : 3048L
China Petroleum & Chemical Corp
29 April 2020
 

 

 

 

 

China Petroleum & Chemical Corporation

The First Quarterly Report for 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

29 April 2020

Beijing, China

 

1 Important notice

 

1.1 The Board of Directors, the Board of Supervisors of China Petroleum & Chemical Corporation ("Sinopec Corp." or "the Company") and its directors, supervisors and senior management warrant that there are no false representations, misleading statements or material omissions contained in this report and severally and jointly accept full responsibility for the authenticity, accuracy and completeness of the information contained in this report.

 

1.2 The first quarterly report for 2020 was approved at the 14th meeting of the Seventh Session of the Board of Directors of Sinopec Corp. All directors attended this meeting.

 

1.3 Mr. Zhang Yuzhuo, Chairman, Mr. Ma Yongsheng, President, Ms. Shou Donghua, Chief Financial Officer and Head of the Financial Department of Sinopec Corp. warrant the authenticity, accuracy and completeness of the financial statements contained in this quarterly report.

 

1.4 The financial statements in this quarterly report were not audited.

 

 

 

 

 

2 Basic information of Sinopec Corp.

2.1 Principal financial data and indicators

2.1.1 Principal financial data and indicators prepared in accordance with China Accounting Standards for Business Enterprises (CASs)

RMB million

 

Items

As of 31 March 2020

As of 31 December 2019

Changes from the end of the preceding year to the end of the reporting period (%)

 

Total assets

1,807,539

1,755,071

3.0

 

Total equity attributable to equity shareholders of the Company

712,350

739,169

(3.6)

 

RMB million

 

Items

Three-month period ended 31 March

Changes over the same period of the preceding year (%)

2020

2019

Net cash flow from operating activities

(68,125)

(14,609)

-

Operating income

555,502

717,579

(22.6)

Net profit attributable to equity shareholders of the Company

(19,782)

14,763

-

Net profit attributable to equity shareholders of the Company excluding extraordinary gains and losses

(20,444)

14,370

-

Weighted average return on net assets (%)

(2.73)

2.03

(4.76) percentage points

Basic earnings per share (RMB)

(0.163)

0.122

-

Diluted earnings per share (RMB)

(0.163)

0.122

-

RMB million

 

Extraordinary items

During the reporting period

 

(income)/expensesRMB million

 

Net gain on disposal of non-current assets

(60)

 

Donations

73

 

Government grants

(1,164)

 

Gains on holding and disposal of various investments

(26)

 

Other extraordinary income and expenses, net

255

 

Subtotal

(922)

 

Tax effect

234

 

Total

(688)

 

Attributable to:

 

Equity shareholders of the Company

(662)

 

Minority interests

(26)

 

2.1.2 Principal financial data and indicators prepared in accordance with International Financial Reporting Standards (IFRS)

RMB million

 

Items

As of 31 March

 2020

As of 31 December

 2019

Changes from the end of the preceding year to the end of the reporting period (%)

 

Total assets

1,807,539

1,755,071

3.0

 

Total equity attributable to shareholders of the Company

711,343

738,150

(3.6)

 

 

RMB million

 

Items

Three-month period ended 31 March

Changes over the same period of the preceding year (%)

2020

2019

Net cash generated from operating activities

(68,125)

(14,609)

-

Operating profit

(26,305)

24,841

-

Net profit attributable to shareholders of the Company

(19,145)

15,468

-

Basic earnings per share (RMB)

(0.158)

0.128

-

Diluted earnings per share (RMB)

(0.158)

0.128

-

Return on net assets (%)

(2.69)

2.09

(4.78) percentage points

 

 

2.2 Total number of shareholders and top ten shareholders at the end of the reporting period

Total number of shareholders at the end of the reporting period

Total number of shareholders was 553,217, including 547,424 holders of domestic A shares and 5,793 holders of overseas H shares.

Top ten shareholders

Name of shareholder

Total number of shares held

Percentage

(%)

Number of shares subject to pledge or lock-ups

Nature of shareholder

China Petrochemical Corporation

82,709,227,393

68.31

0

State-owned share

HKSCC (Nominees) Limited

25,389,028,547

20.97

Unknown

H share

中国证券金融股份有限公司

2,609,312,057

2.16

0

A share

国新投资有限公司

997,141,120

0.82

0

A share

北京诚通金控投资有限公司

756,822,451

0.63

0

A share

中国人寿保险股份有限公司-分红-个人分红-005LFH002

480,607,041

0.40

0

A share

香港中央结算有限公司

463,936,458

0.38

0

A share

中国人寿保险股份有限公司-传统-普通保险产品-005LCT001

449,301,461

0.37

0

A share

中央汇金资产管理有限责任公司

322,037,900

0.27

0

A share

汇添富基金管理股份有限公司-社保基金1103组合

133,250,000

0.11

0

A share

Note Sinopec Century Bright Capital Investment Limited, overseas wholly-owned subsidiary of China Petrochemical Corporation, holds 553,150,000 H shares, which is included in the total number of the shares held by HKSCC (Nominees) Limited.

 

Statement on the connected relationship or acting in concert among the aforementioned shareholders:

 

Apart from中国人寿保险股份有限公司-分红-个人分红-005L-FH002沪和中国人寿保险股份有限公司-传统-普通保险产品-005L-CT001 which were both administrated by 中国人寿保险股份有限公司, Sinopec Corp. is not aware of any connected relationship or acting in concert among or between the above-mentioned shareholders.

 

2.3 Review of operating results

 

In the first quarter of 2020, as the COVID-19 outbreak spread worldwide, the world economy faced mounting downside risk packing with notably increasing instability and uncertainty. China's GDP decreased by 6.8% year on year. Due to plunging market demand for petroleum and petrochemical products coupled with slump of crude oil price, oil and gas industry was severely impacted.

 

Facing the complicated and severe situation, the Company adhered to the principles of "concentrating material tasks, system optimisation, controlling risk and seizing opportunities out of crisis", coordinated epidemic prevention and control with work resumption, brought our advantages of integrated business into full play, optimised production plan, refined operation plan, adjusted products slate, optimised inventory, expanded market, and tapped potentials and reduced cost to minimize the negative impact and maintained safe and steady operations. In particular, to combat the COVID-19, we maintained a stable supply of oil and gas, made great efforts to increase production of medical-use materials, coordinated online and offline non-fuel business to facilitate our customers with wider variety of products and services, and advanced resumption of work and production with industry chain partners.

 

In accordance with China Accounting Standards for Business Enterprises, net profit attributable to equity shareholders of the Company was RMB -19.782 billion. In accordance with IFRS, net profit attributable to equity shareholders of the Company was RMB -19.145 billion.

 

Exploration and Production: Under low crude oil price environment, we pressed ahead with high-efficiency exploration and paid more efforts on profit-oriented development, reduced cost and expenditure on all fronts and accelerated the formation of an integrated value chain of natural gas business including production, supply, storage and marketing. In exploration, we focused on organisation and operation of major projects and new discovery breakthrough. In crude oil development, we pushed to build profitable production capacity, and deepened structure adjustment in mature oil fields. In natural gas development, we expanded the market and promoted a coordinated growth along the value chain. In the first quarter, oil and gas production of the Company was 112.28 million barrels of oil equivalent, among which the production of crude oil was broadly flat compared with the same period of last year. Exploration and Production Segment realised an operating profit of RMB 1.518 billion

 

Exploration and Production

Unit

Three-month period ended 31 March

Changes

2020

2019

(%)

Oil and gas production

million boe

112.28

113.46

(1.0)

Crude oil production

million barrels

70.65

70.81

(0.2)

China

million barrels

62.11

61.55

0.9

Overseas

million barrels

8.54

9.26

(7.8)

Natural gas production

billion cubic feet

249.68

255.79

(2.4)

Realised crude oil price

USD/barrel

49.15

57.66

(14.8)

Realised natural gas price

USD/thousand cubic feet

6.43

7.07

(9.2)

Conversion: For domestic production of crude oil, 1 tonne = 7.10 barrels. For overseas production of crude oil,

1 tonne = 7.21 barrels. For production of natural gas, 1 cubic meter = 35.31 cubic feet.

 

Refining: Facing severe situation of plunged market demand, high-level inventory and slump of crude oil price, we persistently coordinated the integration of production and marketing, optimised allocation of resources and product slate based on market demand and continuously implemented low sulfur fuel oil projects. We coordinated domestic and overseas markets and increased the export of refined oil products, maintaining a steady operation of refining facility. In the first quarter, refinery throughput was 53.74 million tonnes, decreased by 13% year on year. The refining segment's operating loss was RMB 25.794 billion.

 

Refining

Unit

Three-month period ended 31 March

Changes

(%)

2020

2019

Refinery throughput

million tonnes

53.74

61.78

(13.0)

Gasoline, diesel and kerosene production

million tonnes

33.00

39.44

(16.3)

Gasoline

million tonnes

13.02

15.87

(18.0)

Diesel

million tonnes

14.19

16.03

(11.5)

Kerosene

million tonnes

5.79

7.54

(23.2)

Light chemical feedstock production

million tonnes

9.84

10.07

(2.2)

Light product yield

%

75.31

76.14

(0.83)

percentage points

Refining yield

%

94.64

94.76

(0.12)

percentage points

Note: Including 100% production of domestic joint ventures.

 

Marketing and Distribution: To address the dramatic decline of market demand, we enhanced market analysis, pressed ahead measures for market expansion, promoted targeted marketing strategy and tapped the potentials of distribution network. In order to satisfy the market demands during the epidemic, we innovated the non-fuel business model by coordinating online and offline business with wider variety of products and services, which not only realised a beneficial exploration of the sales model but also provided convenience to our consumers. In the first quarter, total sales volume of refined oil products was 53.68 million tonnes and marketing and distribution segment's operating loss was RMB 1.536 billion.

 

Marketing and Distribution

Unit

Three-month period ended 31 March

Changes

(%)

2020

2019

Total sales volume of refined oil products

million tonnes

48.61

62.37

(22.1)

Total domestic sales volume of refined oil products

million tonnes

32.48

45.61

(28.8)

Retail

million tonnes

21.83

30.20

(27.7)

Direct sales & Distribution

million tonnes

10.65

15.41

(30.9)

Annualized average throughput per station

tonnes

2,844

3,939

(27.8)

Note: The total sales volume of refined oil products includes the amount of trading volume.

 

Chemicals: Under the circumstances of dramatic demand decline and price tumble of chemical products, we actively optimised resources allocation, reduced feedstock cost, adjusted operation plan and enhanced the dynamic optimisation of facilities and product chain, and improved the utilisation and production scheduling based on market demand. Giving full play to our industry advantages, we extended business value chain by increasing production of medical-use materials to ensure market supply. We put more efforts on market expansion to create space for production optimisation and adjustment as well as facilities stable operation. In the first quarter, the ethylene production was 3.026 million tonnes, being flat compared with the same period of last year, synthetic resin production increased by 2.8% year on year. The total chemical sales volume was 17.95 million tonnes. The Chemical segment's operating loss was RMB 1.568 billion.

 

Chemicals

Unit

Three-month period ended 31 March

Changes

(%)

2020

2019

Ethylene

thousand tonnes

3,026

3,049

(0.8)

Synthetic resin

thousand tonnes

4,293

4,178

2.8

Synthetic rubber

thousand tonnes

256

271

(5.5)

Monomers and polymers for synthetic fibre

thousand tonnes

2,333

2,575

(9.4)

Synthetic fibre

thousand tonnes

266

322

(17.4)

Note: Including 100% production of domestic joint ventures.

 

Capital expenditure: In the first quarter, total capital expenditures of the Company was RMB 13.2 billion. Capital expenditure for the exploration and production segment was RMB 6.1 billion, mainly for Shengli and Northwest crude oil development projects, Fuling and Weirong shale gas projects. Capital expenditure for the refining segment was RMB 2.4 billion, mainly for Zhongke Refining and Petrochemical project, Zhenhai, Tianjin, Maoming and Beihai refining upgrading projects, low sulfur fuel oil projects and high-end carbon materials projects. Capital expenditure for the marketing and distribution segment was RMB 2.6 billion, mainly for construction of service stations, refined oil products depots and non-fuel businesses. Capital expenditure for the chemicals segment was RMB 2.1 billion, mainly for Zhongke Refining and Petrochemical project, Zhenhai, Gulei, Sinopec-SK ethylene projects renovation, Hainan ethylene projects.

 

2.4 Business Prospects

China's epidemic prevention and control trend has been further consolidated, the country's economic and social activities have gradually returned to normal, the production and living order has been restored at a faster pace, and the pent-up demand for petroleum and petrochemical products is being released. Under this opportunity, we have initiated a campaign that will last for 100 days to address the tough challenges and to improve performance. With management and staffs joint efforts, we are to reinforce measures on market expansion, operations optimisation, cost reduction, tapping potentials, and maintaining safe and steady operations, to minimise the negative impact of the epidemic. We will adjust dynamically the production and operation arrangement and the investment plan, focusing on achieving a high-quality and more profitable operation. While ensuring prevention and control of the pandemic and maintaining safe and stable operation, we will give priority to the following tasks:

 

More vigorous efforts on market expansion. We will keep pace with the market recovery and the industry utilisation rate to seize the market opportunities, provide targeted services to reinforce the market share. Through innovation of business model and analysis of consumption demand changes, we will exploit potential demand to expand market share. By giving full play to the advantages of the industry chain, we will strengthen cooperation with partner and realise coordinative development.

 

More vigorous efforts on optimisation and adjustment. We will bring our advantages of integrated business into full play, refine the allocation of resources, and coordinate all the activities including procurement, transportation, production, storage and marketing. In the E&P segment, we will strengthen the overall coordination of "investment, reserves, output, cost, and profit". In the mid- and down-stream, we will coordinate the operation, feedstock slate, product mix and regional resources, accelerate advantages cultivation and production capacity building, and reinforce the effort in the integration of the production with the marketing.

 

More vigorous efforts on tapping potentials and cost reduction. We will conduct fine management and strengthen cost control involving all employees, covering all resources and conducting in all processes. We will improve the capital efficiency, expand financing channels and reduce financing cost.

 

3 Significant events

3.1 Significant changes in major items contained in the consolidated financial statements prepared in accordance with CASs and the reasons for such changes.

 

Items of Consolidated Balance Sheet

As of 31 March

 2020

As of 31

December

2019

Increase/(Decrease)

Main reasons for changes

Amount

Percentage

RMB million

RMB million

RMB million

%

Financial assets held for trading

2,012

3,319

(1,307)

(39.4)

Receipt of the structured deposits at maturity

Derivative financial assets

14,459

837

13,622

1,627.5

Changes of fair value loss and profit position of derivative hedging financial instruments due to fluctuation of crude oil price

Derivative financial liabilities

26,362

2,729

23,633

866.0

Prepayments

7,296

5,066

2,230

44.0

Increase in projects down payment

Other receivables

57,149

24,109

33,040

137.0

Increase in margin deposit in financial derivatives business due to decline of crude oil price

Short-term loans

98,203

31,196

67,007

214.8

Increase in low-interest short-term loans

Taxes payable

37,622

69,339

(31,717)

(45.7)

Due to the time difference of tax payment, part of the unpaid tax from the end of last year had been paid during this reporting period

Other current liabilities

19,997

-

19,997

-

Issuing short-term debentures payable of RMB 20 billion

Long-term loans

52,870

39,625

13,245

33.4

Increase in project loans of subsidiaries

Other comprehensive income

(7,983)

(321)

(7,662)

 -

Increase in fair value loss of hedging business for crude oil

 

Items of Consolidated Income Statement

For three-month period ended 31 March

Increase/(Decrease)

Main reasons for changes

2020

2019

Amount

Percentage

RMB Million

RMB Million

RMB Million

%

Gains/ (losses) from

changes in fair value

8,342

(2,226)

10,568

-

Increase in fair value profit on derivative financial instruments not qualified as hedging

Impairment losses

(10,360)

136

(10,496)

-

Increase of inventory impairment

 

Items of consolidated cash flow statement

For three-month period ended 31 March

Increase/(Decrease)

Main reasons for changes

2020

2019

Amount

Percentage

RMB

million

RMB

million

RMB million

%

Other cash paid relating to operating activities

(59,028)

(39,806)

(19,222)

-

Mainly due to increase in margin deposit of financial derivative business

Cash received from disposal of investments

3,402

9,636

(6,234)

(64.7)

Decrease in structured deposits at maturity

Other cash received relating to investing activities

19,162

13,165

5,997

45.6

Increase in value of certificate of deposit, over three months, expired and recovered

Other cash paid relating to investing activities

(14,094)

(24,388)

10,294

-

Decrease in the value of certificate of deposit, over three months

Cash received from borrowings

274,615

149,622

124,993

83.5

Increase in low-interest short-term loans

Cash repayments of borrowings

(172,518)

(118,511)

(54,007)

-

Increase in repayment of short-term loans at maturity

 

3.2 This quarterly results announcement is published in both Chinese and English languages. In the event of any inconsistency between the two versions, the Chinese version shall prevail.

 

 

By Order of the Board

Chairman

Zhang Yuzhuo 

29 April, 2020

 

4 Appendix

4.1 Quarterly financial statements prepared under China Accounting Standards for Business Enterprises (CASs)

 

Consolidated Balance Sheet

as at 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

At 31 March 2020

At 31 December 2019

Current assets:

Cash at bank and on hand

138,773

127,927

Financial assets held for trading

2,012

3,319

Derivative financial assets

14,459

837

Accounts receivable

54,246

54,865

Receivables financing

8,746

8,622

Prepayments

7,296

5,066

Other receivables

57,149

24,109

Inventories

183,277

192,442

Other current assets

30,074

28,669

Total current assets

496,032

445,856

Non-current assets:

Long-term equity investments

152,561

152,204

Other equity instrument investments

1,525

1,521

Fixed assets

611,564

622,423

Construction in progress

177,021

173,482

Right-of-use assets

197,349

198,051

Intangible assets

108,039

108,956

Goodwill

8,716

8,697

Long-term deferred expenses

8,531

8,930

Deferred tax assets

29,343

17,616

Other non-current assets

16,858

17,335

Total non-current assets

1,311,507

1,309,215

Total assets

1,807,539

1,755,071

 

 

 

 

 

 

 

 

 

 

 

Current liability:

Short-term loans

98,203

31,196

Derivative financial liabilities

26,362

2,729

Bills payable

14,479

11,834

Accounts payable

154,103

187,958

Contract liabilities

137,563

126,735

Employee benefits payable

7,126

4,769

Taxes payable

37,622

69,339

Other payables

73,908

72,324

Non-current liabilities due within one year

69,903

69,490

Other current liabilities

19,997

-

Total current liabilities

639,266

576,374

Non-current liabilities:

Long-term loans

52,870

39,625

Debentures payable

19,349

19,157

Lease liabilities

178,774

177,674

Provisions

43,375

43,163

Deferred tax liabilities

7,273

6,809

Other non-current liabilities

18,966

15,364

Total non-current liabilities

320,607

301,792

Total liabilities

959,873

878,166

Shareholders' equity:

Share capital

121,071

121,071

Capital reserve

122,128

122,127

Other comprehensive income

(7,983)

(321)

Specific reserve

2,365

1,741

Surplus reserves

207,423

207,423

Retained earnings

267,346

287,128

Total equity attributable to shareholders of the Company

712,350

739,169

Minority interests

135,316

137,736

Total shareholders' equity

847,666

876,905

Total liabilities and shareholders' equity

1,807,539

1,755,071

 

Zhang Yuzhuo Ma Yongsheng

Shou Donghua

Chairman President Chief Financial Officer

 

 

 

 

 

Balance Sheet

as at 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

At 31 March 2020

At 31 December 2019

Current assets

 

Cash at bank and on hand

70,783

54,072

Derivative financial assets

940

940

Accounts receivable

22,184

21,544

Receivables financing

751

207

Prepayments

3,685

2,665

Other receivables

75,833

78,872

Inventories

40,926

49,116

Other current assets

22,555

25,149

Total current assets

237,657

232,565

Non-current assets

Long-term equity investments

306,225

304,687

Other equity instrument investments

395

395

Fixed assets

284,804

291,547

Construction in progress

62,353

60,493

Right-of-use assets

112,968

112,832

Intangible assets

8,654

8,809

Long-term deferred expenses

2,390

2,630

Deferred tax assets

15,847

7,315

Other non-current assets

2,314

2,490

Total non-current assets

795,950

791,198

Total assets

1,033,607

1,023,763

Current liabilities

Short-term loans

64,609

19,919

Derivative financial liabilities

157

157

Bills payable

4,862

4,766

Accounts payable

70,495

75,352

Contract liabilities

4,769

5,112

Employee benefits payable

2,903

1,214

Taxes payable

25,033

43,025

Other payables

108,861

118,064

Non-current liabilities due within one year

59,775

59,596

Other current liabilities

19,997

-

Total current liabilities

361,461

327,205

 

 

 

 

 

 

 

Non-current liabilities

Long-term loans

12,125

12,680

Debentures payable

7,000

7,000

Lease liabilities

108,782

107,783

Provisions

34,825

34,514

Other non-current liabilities

4,337

4,471

Total non-current liabilities

167,069

166,448

Total liabilities

528,530

493,653

Shareholders' equity

Share capital

121,071

121,071

Capital reserve

68,841

68,841

Other comprehensive income

(6,322)

1,181

Specific reserve

1,241

949

Surplus reserves

207,423

207,423

Retained earnings

112,823

130,645

Total shareholders' equity

505,077

530,110

Total liabilities and shareholders' equity

1,033,607

1,023,763

 

Zhang Yuzhuo Ma Yongsheng Shou Donghua

Chairman President Chief Financial Officer

 

 

Consolidated Income Statement

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

 

Items

Three-month period

ended 31 March

2020

 

Three-month period

ended 31 March

2019

I. Operating income

555,502

717,579

II. Total Operating costs

583,107

693,269

Including: Operating costs

499,274

596,412

Taxes and surcharges

49,691

60,459

Selling and distribution expenses

14,653

14,748

General and administrative expenses

14,128

15,485

Research and development costs

1,083

1,292

Financial expenses

2,010

2,330

Exploration expenses,

including dry holes

2,268

2,543

Add: Other income

1,100

761

Investment income

153

1,285

Gains/(losses) from

changes in fair value

8,342

(2,226)

Credit impairment losses

5

(19)

Impairment losses

(10,360)

136

Asset disposal gains/(losses)

60

(64)

III. Operating profit

(28,305)

24,183

Add: Non-operating income

215

243

Less: Non-operating expenses

471

416

IV. Profit before taxation

(28,561)

24,010

Less: Income tax expense

(7,529)

5,539

V. Net profit

(21,032)

18,471

Classification by going concern:

(i) Continuous operating net profit

(21,032)

18,471

(ii) Termination of net profit

-

-

Classification by ownership:

(i)Equity shareholders of the

Company

(19,782)

14,763

(ii) Minority interests

(1,250)

3,708

 

 

 

Consolidated Income Statement (Continued)

 

VI. Other comprehensive income

(7,360)

 3,759

Items that may not be reclassified subsequently to profit or loss:

Changes in fair value of other equity instrument investments

-

1

Items that may be reclassified subsequently to profit or loss:

Other comprehensive income that can be converted into profit or loss under the equity method

 (76)

 66

Cash flow hedges

(8,401)

 4,853

Foreign currency translation differences

1,117

 (1,161)

VII. Total comprehensive income

(28,392)

22,230

Equity shareholders of the Company

(27,103)

19,029

Minority interests

(1,289)

3,201

VIII. Earnings per share:

(i) Basic earnings per share

(RMB/Share)

(0.163)

0.122

(ii) Diluted earnings per

share (RMB/Share)

(0.163)

0.122

 

Zhang Yuzhuo Ma Yongsheng Shou Donghua

 

Chairman President Chief Financial Officer

 

 

 

 

 

Income Statement

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Three-month period

ended 31 March 2020

Three-month period

ended 31 March 2019

I.Operating income

199,942

249,978

 Less: Operating costs

171,987

191,844

Taxes and surcharges

32,996

40,952

Selling and distribution expenses

724

754

General and administrative expenses

6,992

7,612

Research and development costs

1,034

1,197

Financial expenses

2,050

1,635

Exploration expenses,

including dry holes

1,936

2,429

 Add: Other income

896

631

Investment income

814

1,777

Gains from changes in

fair value

400

20

Credit impairment losses

31

5

Impairment losses

(7,992)

-

Asset disposal gains/ (losses)

1

(1)

II. Operating profit

(23,627)

5,987

Add: Non-operating income

33

34

Less: Non-operating expenses

232

147

III. Profit before taxation

(23,826)

5,874

Less: Income tax expense

(6,002)

1,003

IV. Net profit

(17,824)

4,871

(i) Continuous operating net profit

(17,824)

4,871

(ii) Termination of net profit

-

-

V. Other comprehensive income

(7,387)

817

Items that may be reclassified subsequently to profit or loss

Other comprehensive loss that can be converted into profit or loss under the equity method

 49

(33)

Cash flow hedges

 (7,436)

850

VI. Total comprehensive income

(25,211)

5,688

 

Zhang Yuzhuo Ma Yongsheng Shou Donghua

Chairman President Chief Financial Officer

 

 

Consolidated Cash Flow Statement

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Three-month period

ended 31 March 2020

Three-month period

ended 31 March 2019

I. Cash flows from operating activities:

 

 

Cash received from sale of goods and

rendering of services

600,228

760,693

Refund of taxes and levies

818

760

Other cash received relating to operating

activities

35,326

31,379

Sub-total of cash inflows

636,372

792,832

Cash paid for goods and services

(544,121)

(625,310)

Cash paid to and for employees

(16,826)

(17,224)

Payments of taxes and levies

(84,522)

(125,101)

Other cash paid relating to operating

activities

(59,028)

(39,806)

Sub-total of cash outflows

(704,497)

(807,441)

Net cash flow from operating activities

(68,125)

(14,609)

II.Cash flows from investing activities:

Cash received from disposal of investments

3,402

9,636

Cash received from returns on investments

986

1,288

Net cash received from disposal of fixed assets, intangible assets and other long-term assets

18

24

Other cash received relating to investing

activities

19,162

13,165

Sub-total of cash inflows

23,568

24,113

Cash paid for acquisition of fixed assets, intangible assets and other long-term assets

(22,327)

(23,514)

Cash paid for acquisition of investments

(1,672)

(1,793)

Other cash paid relating to investing

activities

(14,094)

(24,388)

Sub-total of cash outflows

(38,093)

(49,695)

Net cash flow from investing activities

(14,525)

(25,582)

III.Cash flows from financing activities:

Cash received from capital contributions

260

94

Including: Cash received from minority shareholders' capital contributions to subsidiaries

260

94

Cash received from borrowings

274,615

149,622

 

Consolidated Cash Flow Statement (Continued)

 

Other cash received relating to financing activities

276

190

Sub-total of cash inflows

275,151

149,906

Cash repayments of borrowings

(172,518)

(118,511)

Cash paid for dividends, profits

distribution or interest

(1,557)

(1,396)

Including: Subsidiaries' cash payments for distribution of dividends or profits to minority shareholders

(160)

(235)

Other cash paid relating to financing

activities

(3,492)

(630)

Sub-total of cash outflows

(177,567)

(120,537)

Net cash flow from financing activities

97,584

29,369

IV. Effects of changes in foreign exchange rate

553

(340)

V. Net increase/(decrease) in cash and cash equivalents

15,487

(11,162)

AddInitial balance of cash and cash equivalents

60,313

111,922

VI. Ending balance of cash and cash equivalents

75,800

100,760

 

Zhang Yuzhuo Ma Yongsheng Shou Donghua

Chairman President Chief Financial Officer

 

 

 

 

Cash Flow Statement

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Three-month period

ended 31 March 2020

Three-month period

ended 31 March 2019

I.Cash flows from operating activities:

 

 

Cash received from sale of goods and rendering of services

217,331

280,152

Refund of taxes and levies

798

519

Other cash received relating to operating activities

1,619

757

Sub-total of cash inflows

219,748

281,428

Cash paid for goods and services

(175,248)

(208,261)

Cash paid to and for employees

(8,835)

(9,274)

Payments of taxes and levies

(53,244)

(76,898)

Other cash paid relating to operating activities

(5,349)

(2,939)

Sub-total of cash outflows

(242,676)

(297,372)

Net cash flow from operating activities

(22,928)

(15,944)

II.Cash flows from investing activities:

Cash received from disposal of investments

4,759

9,285

Cash received from returns on investments

1,224

1,270

Net cash received from disposal of fixed assets, intangible assets and other long-term assets

3

3

Other cash received relating to investing activities

44,575

9,933

Sub-total of cash inflows

50,561

20,491

Cash paid for acquisition of fixed assets, intangible assets and other long-term assets

(9,307)

(7,459)

Cash paid for acquisition of investments

(2,807)

(1,376)

Other cash paid relating to investing activities

(47,607)

(10,800)

Sub-total of cash outflows

(59,721)

(19,635)

Net cash flow from investing activities

(9,160)

856

III.Cash flows from financing activities:

Cash received from borrowings

130,458

39,186

Other cash received relating to financing activities

57,475

-

Sub-total of cash inflows

187,933

39,186

Cash repayments of borrowings

(66,328)

(35,016)

Cash paid for dividends or interest

(875)

(1,476)

Other cash paid relating to financing activities

(72,108)

(266)

Sub-total of cash outflows

(139,311)

(36,758)

Net cash flow from financing activities

48,622

2,428

 

Cash Flow Statement (Continued)

 

IV. Net increase/(decrease) in cash and cash equivalents

16,534

(12,660)

AddInitial balance of cash and cash equivalents

38,616

59,120

V. Ending balance of cash and cash equivalents

55,150

46,460

 

Zhang Yuzhuo Ma Yongsheng Shou Donghua

Chairman President Chief Financial Officer

 

 

 

 

 

 

Segment Reporting

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Three-month period

ended 31 March 2020

Three-month period

ended 31 March 2019

Income from principal operations

Exploration and production

External sales

26,944

29,367

Inter-segment sales

18,238

22,089

Subtotal

45,182

51,456

Refining

External sales

25,145

34,002

Inter-segment sales

217,468

255,752

Subtotal

242,613

289,754

Marketing and distribution

External sales

248,725

321,636

Inter-segment sales

1,226

965

Subtotal

249,951

322,601

Chemicals

External sales

71,815

110,990

Inter-segment sales

10,884

17,121

Subtotal

82,699

128,111

Corporate and others

External sales

170,003

205,504

Inter-segment sales

131,839

154,677

Subtotal

301,842

360,181

Elimination of inter-segment sales

(379,655)

(450,604)

Consolidated income from principal operations

542,632

701,499

Income from other operations

Exploration and production

1,272

1,821

Refining

932

1,251

Marketing and distribution

6,939

8,850

Chemicals

3,401

3,733

Corporate and others

326

425

Consolidated income from other operations

12,870

16,080

 

Segment Reporting (Continued)

 

Consolidated operating income

555,502

717,579

Operating (loss)/profit

By segment

Exploration and production

404

1,581

Refining

(26,299)

11,481

Marketing and distribution

(2,621)

7,990

Chemicals

(1,767)

6,827

Corporate and others

(5,667)

(582)

Elimination

-

(540)

Total segment operating profit

(35,950)

26,757

Investment income

Exploration and production

476

777

Refining

(680)

(394)

Marketing and distribution

657

215

Chemicals

(66)

1,047

Corporate and others

(234)

(360)

Total segment investment income

153

1,285

Financial expenses

(2,010)

(2,330)

Gains/(losses) from changes in fair value

8,342

(2,226)

Asset disposal gains/(losses)

60

(64)

Other income

1,100

761

Operating profit

(28,305)

24,183

Add: Non-operating income

215

243

Less: Non-operating expenses

471

416

Profit before taxation

(28,561)

24,010

 

4.2 Quarterly financial statements prepared under International Financial Reporting

Standards (IFRS)

 

Consolidated Income Statement

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Three-month period

ended 31 March 2020

Three-month period

ended 31 March 2019

Turnover and other operating revenues

Turnover

542,632

701,499

Other operating revenues

12,870

16,080

Subtotal

555,502

717,579

Operating expenses

Purchased crude oil, products and operating

supplies and expenses

(484,322)

(572,138)

Selling, general and administrative expenses

(10,488)

(11,575)

Depreciation, depletion and amortisation

(25,070)

(25,998)

Exploration expenses, including dry holes

(2,268)

(2,543)

Personnel expenses

(18,844)

(17,361)

Taxes other than income tax

(49,691)

(60,459)

Other operating revenue/(expense), net

8,876

(2,664)

Total operating expenses

(581,807)

(692,738)

Operating profit

(26,305)

24,841

Finance costs

Interest expense

(3,896)

(4,301)

Interest income

1,085

1,924

Foreign currency exchange loss, net

801

47

Net finance costs

(2,010)

(2,330)

Investment income

29

55

Share of profits less losses from associates and joint ventures

472

2,232

Profit before taxation

(27,814)

24,798

Income tax expense

7,529

(5,539)

Profit for the period

(20,285)

19,259

Attributable to

 Owners of the Company

(19,145)

15,468

 Non-controlling interests

(1,140)

3,791

Profit for the period

(20,285)

19,259

Earnings per share

Basic earnings per share (RMB)

(0.158)

0.128

Diluted earnings per share (RMB)

(0.158)

0.128

 

Consolidated Statement of Comprehensive Income

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Three-month period ended 31 March 2020

Three-month period ended 31 March 2019

Profit for the period

(20,285)

19,259

Other comprehensive income:

(7,360)

3,759

Items that may not be reclassified subsequently to profit or loss:

Equity investments at fair value through other comprehensive income

-

1

Items that may be reclassified subsequently to profit or loss:

Share of other comprehensive income of associates and joint ventures

(76)

66

Cash flow hedges

(8,401)

4,853

Foreign currency translation differences

1,117

(1,161)

Total comprehensive income

(27,645)

23,018

Attributable to:

Shareholders of the Company

(26,466)

19,734

Non-controlling interests

(1,179)

3,284

 

 

Consolidated Balance Sheet

as at 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

At 31 March 2020

At 31 December 2019

Non-current assets

Property, plant and equipment, net

611,508

622,409

Construction in progress

 177,021

173,482

Right-of-use assets

 266,992

267,860

Goodwill

 8,716

8,697

Interest in associates

 96,691

95,737

Interest in joint ventures

 55,870

56,467

Financial assets at fair value through other

 comprehensive income

 1,525

1,521

Deferred tax assets

 29,343

17,616

Long-term prepayments and other non-current assets

 63,841

65,426

Total non-current assets

1,311,507

 1,309,215

Current assets:

Cash and cash equivalents

 75,800

60,313

Time deposits with financial institutions

 62,973

67,614

Financial assets at fair value through profit and loss

 2,012

3,319

Derivatives financial assets

 14,459

837

Trade accounts receivable and bills receivable

 54,246

54,865

Financial assets at fair value through other comprehensive income

 8,746

8,622

Inventories

 183,277

192,442

Prepaid expenses and other current assets

94,519

57,844

Total current assets

496,032

445,856

Current liabilities

Short-term debts

 97,476

40,521

Loans from Sinopec Group Company and fellow subsidiaries

 73,290

43,289

Lease liabilities

 15,586

15,198

Derivatives financial liabilities

 26,362

2,729

Trade accounts payable and bills payable

 168,582

199,792

Contract liabilities

 137,563

126,735

Other payables

 119,729

144,846

Income tax payable

 678

3,264

Total current liabilities

639,266

576,374

Consolidated Balance Sheet (Continued)

 

Net current liabilities

143,234

130,518

Total assets less current liabilities

1,168,273

1,178,697

Non-current liabilities

Long-term debts

 56,235

49,156

Loans from Sinopec Group Company and fellow subsidiaries

 15,984

9,626

Lease liabilities

178,774

177,674

Deferred tax liabilities

7,273

6,809

Provisions

43,375

43,163

Other non-current liabilities

 20,024

16,434

Total non-current liabilities

321,665

302,862

Total net assets

846,608

875,835

Equity

Share capital

 121,071

121,071

Reserves

 590,272

617,079

Total equity attributable to shareholders of the Company

711,343

738,150

Non-controlling interests

135,265

137,685

Total equity

846,608

875,835

 

 

Consolidated Statement of Cash Flows

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Three-month period ended 31 March 2020

Three-month period ended 31 March 2019

Net cash generated from operating activities(a)

(68,125)

 (14,609)

Investing activities

Capital expenditure

(20,432)

 (21,855)

Exploratory wells expenditure

(1,895)

 (1,659)

Purchase of investments, investments in associates and

investments in joint ventures

(1,672)

 (1,793)

Proceeds from disposal of investments and investments in associates

3,402

 9,636

Proceeds from disposal of property, plant, equipment and other non-current assets

18

24

Increase in time deposits with maturities over three months

 (13,912)

 (24,388)

Decrease in time deposits with maturities over three months

18,553

 11,855

Interest received

609

 1,310

Investment and dividend income received

986

 1,288

Repayments of other investing activities

(182)

-

Net cash used in investing activities

(14,525)

(25,582)

Financing activities

Proceeds from bank and other loans

274,615

 149,622

Repayments of bank and other loans

 (172,518)

 (118,511)

Contributions to subsidiaries from non-controlling interests

260

 94

Distributions by subsidiaries to non-controlling interests

(160)

 (319)

Interest paid

(1,397)

 (1,077)

Payments made to acquire non-controlling interests

(1,117)

-

Repayments of lease liabilities

(2,375)

(440)

Proceeds from other financing activities

276

-

Net cash used in financing activities

97,584

 29,369

Net increase/ (decrease) in cash and cash equivalents

14,934

 (10,822)

Cash and cash equivalents at 1 January

60,313

 111,922

Effect of foreign currency exchange rate changes

553

 (340)

Cash and cash equivalents at 31 March

75,800

 100,760

 

Note to consolidated statement of Cash Flows

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

(a) Reconciliation of profit before taxation to net cash generated from operating activities

Items

Three-month period ended 31 March 2020

Three-month period ended 31 March 2019

Operating activities

Profit before taxation

(27,814)

 24,798

Adjustments for:

Depreciation, depletion and amortisation

25,070

25,998

Dry hole costs written off

1,863

 1,836

Share of profits from associates and joint ventures

(472)

 (2,232)

Investment income

(29)

 (55)

Interest income

(689)

 (1,924)

Interest expense

3,683

 4,301

Gain/(loss) on foreign currency exchange rate changes and derivative financial instruments

(8,589)

 1,295

Gain/(loss) on disposal of property, plant, equipment and other non-current assets, net

(3)

85

Impairment reversal on assets

10,360

 (136)

Credit impairment losses

(5)

 19

Operating profit before change of operating capital

3,375

 53,985

Accounts receivable and other current assets

 (48,286)

 (7,199)

Inventories

(1,163)

 (30,127)

Accounts payable and other current liabilities

 (16,994)

 (24,314)

Subtotal

 (63,068)

 (7,655)

Income tax paid

(5,057)

 (6,954)

Net cash generated from operating activities

(68,125)

(14,609)

 

 

Segment Reporting

for the three-month period ended 31 March 2020

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Three-month period ended 31 March 2020

Three-month period ended 31 March 2019

Turnover

Exploration and production

External sales

26,944

29,367

Inter-segment sales

18,238

22,089

Subtotal

45,182

51,456

Refining

External sales

25,145

34,002

Inter-segment sales

217,468

255,752

Subtotal

242,613

289,754

Marketing and distribution

External sales

248,725

321,636

Inter-segment sales

1,226

965

Subtotal

249,951

322,601

Chemicals

External sales

71,815

110,990

Inter-segment sales

10,884

17,121

Subtotal

82,699

128,111

Corporate and others

External sales

170,003

205,504

Inter-segment sales

131,839

154,677

Subtotal

301,842

360,181

Elimination of inter-segment sales

(379,655)

(450,604)

Turnover

542,632

701,499

Other operating revenues

Exploration and production

1,272

1,821

Refining

932

1,251

Marketing and distribution

6,939

8,850

Chemicals

3,401

3,733

Corporate and others

326

425

Other operating revenues

12,870

16,080

Turnover and other operating revenues

555,502

717,579

Result

Operating (loss)/profit

 

Segment Reporting (Continued)

 

By segment

Exploration and production

1,518

2,143

Refining

(25,794)

11,963

Marketing and distribution

(1,536)

7,866

Chemicals

(1,568)

6,953

Corporate and others

1,075

(3,544)

Elimination

-

(540)

Total segment operating profit

(26,305)

24,841

Share of profits from associates and joint ventures

Exploration and production

476

777

Refining

(682)

(404)

Marketing and distribution

287

247

Chemicals

(76)

1,061

Corporate and others

467

551

Aggregate share of profits from associates and joint ventures

472

2,232

Investment income/(losses)

Exploration and production

-

(1)

Refining

2

10

Marketing and distribution

14

45

Chemicals

8

1

Corporate and others

5

-

Aggregate investment income

29

55

Net finance costs

(2,010)

(2,330)

Profit before taxation

(27,814)

24,798

 

4.3 Differences between Consolidated Financial Statements prepared in accordance with the accounting policies complying with CASs and IFRS (unaudited)

 

Other than the differences in the classifications of certain financial statements captions and the accounting for the items described below, there are no material differences between the Group's consolidated financial statements prepared in accordance with the accounting policies complying with CASs and IFRS. The reconciliation presented below is included as supplemental information, is not required as part of the basic financial statements and does not include differences related to classification, presentation or disclosures. Such information has not been subject to independent audit or review. The major differences are:

 

(i) Government Grants

 

Under CASs, grants from the government are credited to capital reserve if required by relevant governmental regulations. Under IFRS, government grants relating to the purchase of fixed assets are recognized as deferred income and are transferred to the income statement over the useful life of these assets.

 

 

(ii) Safety Production Fund

 

Under CASs, safety production fund should be recognized in profit or loss with a corresponding increase in reserve according to PRC regulations. Such reserve is reduced for expenses incurred for safety production purposes or, when safety production related fixed assets are purchased, is reduced by the purchased cost with a corresponding increase in the accumulated depreciation. Such fixed assets are not depreciated thereafter. Under IFRS, payments are expensed as incurred, or capitalised as fixed assets and depreciated according to applicable depreciation methods.

 

Effects of major differences between the net profit under CASs and the profit for the period under IFRS are analysed as follows:

 

Prepared by: China Petroleum & Chemical Corporation

 

Units: million Currency: RMB Type: unaudited

Items

Three-month period ended 31 March 2020

Three-month period ended 31 March 2019

Net profit under CASs

(21,032)

18,471

Adjustments:

Government grants (i)

12

13

Safety production fund (ii)

735

775

Profit for the period under IFRS

(20,285)

19,259

 

 

Effects of major differences between the shareholders' equity under CASs and the total equity under IFRS are analysed as follows:

 

Units: million Currency: RMB Type: unaudited

Items

At 31 March 2020

At 31 December 2019

Shareholders' equity under CASs

847,666

876,905

Adjustments:

Government grants(i)

(1,058)

(1,070)

Total equity under IFRS

846,608

875,835

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRFEAPLNASLEEEA
12
Date   Source Headline
28th Oct 202210:14 amRNS3rd Quarter Results
3rd Oct 20227:00 amRNSStatement re Intention to Delist ADSs from the LSE
30th Aug 20227:00 amRNSHalf-year Report
12th Aug 202210:23 amRNSINTENTION TO DELIST ADSs FROM THE NYSE
27th Jun 20229:46 amRNSReport on Payments to Govts
27th Apr 20229:47 amRNS1st Quarter Results
28th Mar 20227:00 amRNSAnnual Financial Report-2
28th Mar 20227:00 amRNSAnnual Financial Report-1
27th Jan 20229:49 amRNSTrading Statement
28th Oct 202110:54 amRNS3rd Quarter Results
31st Aug 20217:00 amRNSHalf-year Report
1st Jul 202111:36 amRNSTrading Statement
16th Jun 20219:46 amRNSReport on Payments to Govts
25th May 202111:31 amRNSResult of AGM
28th Apr 20219:39 amRNS1st Quarter Results
29th Mar 20217:00 amRNSEstimated Increase in Profit for Q1 2021
29th Mar 20217:00 amRNSAnnual Financial Report-part 2
29th Mar 20217:00 amRNSAnnual Financial Report
28th Oct 20208:56 amRNS3rd Quarter Results
1st Sep 20207:00 amRNSHalf-year Report
28th May 20209:46 amRNSReport on Payments to Govts
29th Apr 202010:03 amRNS1st Quarter Results
23rd Apr 202012:38 pmRNSAnnual Financial Report - Part 2
23rd Apr 202012:37 pmRNSAnnual Financial Report - Part 1
30th Mar 20207:00 amRNSFinal Results - Part 2
30th Mar 20207:00 amRNSFinal Results - Part 1
10th Dec 20199:37 amRNSStatement re Restructuring Oil&Gas Pipeline Assets
30th Oct 20199:16 amRNS3rd Quarter Results
27th Aug 20197:00 amRNSHalf-year Report
31st May 20199:36 amRNSReport on Payments to Govts
29th Apr 201911:49 amRNS1st Quarter Results
25th Mar 20198:19 amRNSFinal Results - Part 2
25th Mar 20198:17 amRNSFinal Results - Part 1
25th Jan 20199:21 amRNSProgress Update Announcement
25th Jan 20199:11 amRNSOperational Statistics for 2018
25th Jan 20199:07 amRNSAnnouncement on Preliminary Financial Data of 2018
4th Jan 201910:45 amRNSFurther re ANNOUNCEMENT UNUSUAL PRICE MOVEMENT
27th Dec 20182:19 pmRNSStmnt re Share Price Movement
30th Oct 201812:08 pmRNS3rd Quarter Results
16th Oct 201812:49 pmRNSEstimated Increase in Profit ended 30 Sep. 2018
28th Aug 20187:10 amRNSHalf-year Report
24th Jul 201810:13 amRNSEstimated Increase in Profit for the 1H 2018
13th Jun 201810:58 amRNSReport on Payments to Govts
15th May 20183:04 pmRNSResult of AGM
26th Apr 201811:31 amRNS1st Quarter Results
26th Mar 20187:23 amRNSAnnual Financial Report
30th Oct 201710:38 amRNS3rd Quarter Results
22nd Sep 201711:50 amRNSDirectorate Change
29th Aug 20177:00 amRNSHalf-year Report
30th Jun 201710:48 amRNSReport on Payments to Govts for 2015 and 2016
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.